Stock overview
Amgen Inc.
Explore the company, reported ownership, price history, and available source evidence.
Amgen develops biotechnology medicines for oncology, inflammation, cardiovascular disease, bone health, and rare diseases.
- Last close
- $443.89
- · AMGN
- Tracked holders
- 3 funds
- Latest available 13F per fund
AMGN · USD
Price
Close · Nov 18, 2026
- Range low
- $198.88
- Range high
- $478.48
- Observations
- 1255
- Session date
- Nov 18, 2026
Nov 18, 2021–Nov 18, 2026. Regular market hours only. Historical prices are unadjusted; splits and other corporate actions can affect comparisons.
Investor Popularity
Rows are narrowed by movement, fund type, and position size.
| Fund | Move | Value | Weight |
|---|---|---|---|
| Gotham Asset Management largest tracked holder Q3 2026 · filed Nov 16, 2026 · SEC filing | +101% 26'Q3 | $39,419,194 | 0.08% |
SEC Forms 4/5
Insiders
Financials
Official-source analysis
AI Earnings Report
No published AI Earnings Report yet
We publish a cited AI Earnings Report after an eligible official earnings filing is accepted and passes validation.
Options market